Beigene, Ltd. (NASDAQ:ONC) Insider Lai Wang Sells 5,000 Shares

Beigene, Ltd. (NASDAQ:ONCGet Free Report) insider Lai Wang sold 5,000 shares of the stock in a transaction on Friday, February 21st. The stock was sold at an average price of $257.23, for a total value of $1,286,150.00. Following the sale, the insider now owns 920,920 shares in the company, valued at approximately $236,888,251.60. This represents a 0.54 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Beigene Stock Performance

NASDAQ:ONC opened at $259.70 on Wednesday. The company has a current ratio of 1.93, a quick ratio of 1.72 and a debt-to-equity ratio of 0.05. Beigene, Ltd. has a 1 year low of $126.97 and a 1 year high of $265.89. The firm has a market cap of $25.41 billion, a price-to-earnings ratio of -31.52, a P/E/G ratio of 7.73 and a beta of 0.63.

Beigene Company Profile

(Get Free Report)

BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.

Featured Articles

Receive News & Ratings for Beigene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beigene and related companies with MarketBeat.com's FREE daily email newsletter.